Loading insider details...
Beta
Latest Form 4 (Jun 3, 2026): Grant/Award of 40,412 DMAC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 40,412 | n/a |
| Feb 24, 2025 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 64,242 | n/a |
| Mar 7, 2024 | Ambrx Biopharma, Inc. (AMAM) | Disposition to Issuer | 48,202 | n/a |
| Jan 8, 2024 | SEELOS THERAPEUTICS, INC. (SEEL) | Grant/Award | 1,666 | n/a |
| Dec 15, 2022 | ZyVersa Therapeutics, Inc. (ZVSA) | Other (see footnotes) | 1,377,598 | n/a |
| Mar 10, 2022 | Larkspur Health Acquisition Corp. (LSPR) | Other (see footnotes) | 42,005 | n/a |